Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class ITerminatedOct 7, 2015Prolotherapy with PhenolNon-Sterility: Hartley Medical Center Pharmacy, Inc. is recalling Prolotherapy with Phenol due to non-sterility concerns.Hartley Medical Center Pharmacy, Incorporated · D-1830-2015Class ITerminatedOct 7, 2015Prolotherapy with PhenolNon-Sterility: Hartley Medical Center Pharmacy, Inc. is recalling Prolotherapy with Phenol due to non-sterility concerns.Hartley Medical Center Pharmacy, Incorporated · D-1829-2015Class IIITerminatedOct 7, 2015Rodan & Fields Proactiv SolutionSubpotent Drug: Salicylic acid is subpotent.Guthy-Renker LLC · D-0005-2016Class IIITerminatedOct 7, 2015Rodan & Fields Proactiv SolutionSubpotent Drug: Salicylic acid is subpotent.Guthy-Renker LLC · D-0004-2016Class IIITerminatedOct 7, 2015Rodan & Fields Proactiv SolutionSubpotent Drug: Salicylic acid is subpotent.Guthy-Renker LLC · D-0003-2016Class IIITerminatedOct 7, 2015Rodan & Fields Proactiv SolutionSubpotent Drug: Salicylic acid is subpotent.Guthy-Renker LLC · D-0002-2016Class IIITerminatedOct 7, 2015Rodan & Fields Proactiv SolutionSubpotent Drug: Salicylic acid is subpotent.Guthy-Renker LLC · D-0001-2016Class ITerminatedSep 30, 2015PHENYLephrine HClPresence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride, USP injection which were subsequently recalled due to the presence of...Pharmedium Services, LLC · D-1828-2015Class ITerminatedSep 30, 2015PHENYLephrine HClPresence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride, USP injection which were subsequently recalled due to the presence of...Pharmedium Services, LLC · D-1827-2015Class ITerminatedSep 30, 2015PHENYLephrine HClPresence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride, USP injection which were subsequently recalled due to the presence of...Pharmedium Services, LLC · D-1826-2015Class ITerminatedSep 30, 2015Fentanyl CitratePresence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride, USP injection which were subsequently recalled due to the presence of...Pharmedium Services, LLC · D-1825-2015Class ITerminatedSep 30, 2015Morphine SulfatePresence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride, USP injection which were subsequently recalled due to the presence of...Pharmedium Services, LLC · D-1824-2015Class ITerminatedSep 30, 2015Bupivacaine HCl 0.0625%Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride, USP injection which were subsequently recalled due to the presence of...Pharmedium Services, LLC · D-1823-2015Class ITerminatedSep 30, 2015PHENYLephrine HClPresence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride, USP injection which were subsequently recalled due to the presence of...Pharmedium Services, LLC · D-1822-2015Class ITerminatedSep 30, 2015PHENYLephrine HClPresence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride, USP injection which were subsequently recalled due to the presence of...Pharmedium Services, LLC · D-1821-2015Class IITerminatedSep 30, 2015BLEPHAMIDEPresence of Particulate Matter: Due to customer complaints of small black particles, identified as part of the ointment tube cap, generated by the action of unscrewing...Allergan Sales, LLC · D-1820-2015Class IITerminatedSep 30, 2015FML (fluorometholone ophthalmic ointment) 0.1%Presence of Particulate Matter: Due to customer complaints of small black particles, identified as part of the ointment tube cap, generated by the action of unscrewing...Allergan Sales, LLC · D-1819-2015Class IITerminatedSep 30, 2015Refresh P.MPresence of Particulate Matter: Due to customer complaints of small black particles, identified as part of the ointment tube cap, generated by the action of unscrewing...Allergan Sales, LLC · D-1818-2015Class IITerminatedSep 30, 2015Refresh Lacri-LubePresence of Particulate Matter: Due to customer complaints of small black particles, identified as part of the ointment tube cap, generated by the action of unscrewing...Allergan Sales, LLC · D-1817-2015Class IITerminatedSep 30, 20150.9% Sodium Chloride InjectionLack of Assurance of Sterility: Recalling firm reported a complaint for mold on the interior surface of the overpouch.Baxter Healthcare Corporation · D-1816-2015Class IIOngoingSep 30, 20151% Lidocaine HCl InjectionPresence of Particulate Matter: particulate matter identified as iron oxide, was found embedded in the neck of glass vials.Hospira, Inc. · D-1815-2015Class IITerminatedSep 23, 2015Cevimeline Hydrochloride CapsulesFailed Stability Specifications: product may not meet specification limit for assay test.Apotex Inc. · D-1814-2015Class IIITerminatedSep 23, 2015ClomiPHENE CITRATE TabletsChemical Contamination: impurity failure due to chemical contamination of the active ingredient.EMD Serono, Inc. · D-1813-2015Class IITerminatedSep 23, 2015Tri-Mix T-50/PGE 2/LIDO 2 0.09/0.32/0.04 InjectableLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1812-2015Class IITerminatedSep 23, 2015Tri-Mix T-50/PGE 2/LIDO 2 0.03/0.18/0.09 InjectableLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1811-2015Class IITerminatedSep 23, 2015Tri-Mix T-50/PGE 1 0.14/0.08 InjectableLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1810-2015Class IITerminatedSep 23, 2015Tri-Mix T-50 8.8 mg/0.29 mg/2.9 mcg InjectableLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1809-2015Class IITerminatedSep 23, 2015Tri-Mix T-106/PGE 2 0.1/0.14 InjectableLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1808-2015Class IITerminatedSep 23, 2015Tri-Mix T-106Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1807-2015Class IITerminatedSep 23, 2015Tri-Mix T-105Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1806-2015Class IITerminatedSep 23, 2015Tri-Mix T-102/PGE 2/LIDO 2 0.06/0.3/0.2 InjectableLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1805-2015Class IITerminatedSep 23, 2015Tri-Mix T-102Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1804-2015Class IITerminatedSep 23, 2015Tri-Mix T-101Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1803-2015Class IITerminatedSep 23, 2015Tri-Mix SUPERLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1802-2015Class IITerminatedSep 23, 2015Tri-Mix ST9ELack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1801-2015Class IITerminatedSep 23, 2015Tri-Mix ST9CLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1800-2015Class IITerminatedSep 23, 2015Tri-Mix ST9ALack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1799-2015Class IITerminatedSep 23, 2015Tri-Mix ST9ALack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1798-2015Class IITerminatedSep 23, 2015Tri-Mix ST4/PGE 2/LIDO 2 0.1/0.05/0.05 InjectableLack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1797-2015Class IITerminatedSep 23, 2015Tri-Mix ST4Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterilityThe Compounding Pharmacy of America · D-1796-2015